Lululemon (LULU) Stock Sinks As Market Gains: Here's Why

Lululemon (LULU) shares recently declined 2.64% to $195.19, contributing to an 11.33% drop over the past month and significantly underperforming the broader market and Consumer Discretionary sector. Ahead of its upcoming earnings report, the company faces lowered analyst expectations, with Q1 EPS projected to fall 9.21% year-over-year to $2.86, despite an anticipated 6.91% revenue increase to $2.53 billion. This negative earnings outlook is reflected in a 0.47% reduction in the Zacks Consensus EPS estimate over 30 days and a current Zacks Rank of #4 (Sell), signaling potential continued pressure despite its current valuation discount (Forward P/E of 13.9 vs. industry 15.78).

Analysis

Lululemon (LULU) is exhibiting significant weakness, with its stock declining 11.33% over the past month, a stark underperformance compared to the S&P 500's 3.46% gain and the Consumer Discretionary sector's 0.32% rise. This negative momentum precedes an upcoming earnings report where expectations are notably pessimistic. Analysts forecast a 9.21% year-over-year decline in earnings per share (EPS) to $2.86, a concerning trend given that revenues are simultaneously expected to increase by 6.91% to $2.53 billion, pointing toward significant margin compression. This profitability challenge appears to extend through the full year, with consensus estimates projecting a 1.5% drop in annual EPS despite a 5.6% revenue increase. The bearish sentiment is further reinforced by a 0.47% downward revision in the Zacks Consensus EPS estimate over the last 30 days and a corresponding Zacks Rank of #4 (Sell). While the stock trades at a forward P/E of 13.9, a discount to its industry average of 15.78, this lower valuation is overshadowed by the deteriorating earnings outlook and negative analyst revisions.

Key Decisions for Investors

• Given the stock's significant underperformance and the Zacks #4 (Sell) rating, investors should exercise caution and may consider reducing exposure ahead of the earnings announcement.
• Closely scrutinize the upcoming earnings report for management's explanation of margin pressure, as the divergence between expected revenue growth (+6.91%) and the sharp EPS decline (-9.21%) is a primary risk factor.
• Be wary of viewing the stock's valuation discount as a buying signal; the negative earnings revisions and poor momentum suggest it could be a value trap rather than an undervalued opportunity.
• Investors should monitor for any stabilization or positive revision in analyst EPS estimates post-earnings as a potential catalyst for a change in the current bearish narrative.